Expression of Human Telomerase Reverse Transcriptase (hTERT) Splice Variants In Chronic Lymphocytic Leukemia (CLL)
Marzia Palma(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Parviz Kokhaei(Arak University of Medical Sciences), Anders Österborg(Karolinska University Hospital), Lotta Hansson(Karolinska Institutet), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Aniruddha Choudhury(Greenslopes Private Hospital)
Cited by 0
Related Papers
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312